Characterization of CD22 expression in acute lymphoblastic leukemia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of CD22 expression in acute lymphoblastic leukemia
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume 62, Issue 6, Pages 964-969
Publisher
Wiley
Online
2015-03-02
DOI
10.1002/pbc.25410
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia
- (2013) Hagop Kantarjian et al. CANCER
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
- (2012) W. Haso et al. BLOOD
- Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia
- (2012) Robert J. Kreitman et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemoimmunotherapy in acute lymphoblastic leukemia
- (2011) Dieter Hoelzer et al. BLOOD REVIEWS
- Synergistic Antitumor Activity of Anti-CD25 Recombinant Immunotoxin LMB-2 with Chemotherapy
- (2011) R. Singh et al. CLINICAL CANCER RESEARCH
- Flow cytometric analysis of de novo acute lymphoblastic leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group
- (2011) Shotaro Iwamoto et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases
- (2011) Sara Raponi et al. LEUKEMIA & LYMPHOMA
- A Flow Cytometry Method to Quantitate Internalized Immunotoxins Shows that Taxol Synergistically Increases Cellular Immunotoxins Uptake
- (2010) Y. Zhang et al. CANCER RESEARCH
- Anti-CD22 Immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-Positive Hematologic Malignancies of Childhood: Preclinical Studies and Phase I Clinical Trial
- (2010) A. S. Wayne et al. CLINICAL CANCER RESEARCH
- Variables affecting the quantitation of CD22 in neoplastic B cells
- (2010) Gregory A. Jasper et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Surface antigens analysis reveals significant expression of candidate targets for immunotherapy in adult acute lymphoid leukemia
- (2010) Pier Paolo Piccaluga et al. LEUKEMIA & LYMPHOMA
- Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study
- (2009) Richard H. Ko et al. JOURNAL OF CLINICAL ONCOLOGY
- Soluble CD22 as a tumor marker for hairy cell leukemia
- (2008) K. Matsushita et al. BLOOD
- High Shed Antigen Levels within Tumors: An Additional Barrier to Immunoconjugate Therapy
- (2008) Y. Zhang et al. CLINICAL CANCER RESEARCH
- Chemoimmunotherapy Reinduction With Epratuzumab in Children With Acute Lymphoblastic Leukemia in Marrow Relapse: A Children's Oncology Group Pilot Study
- (2008) Elizabeth A. Raetz et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started